User menu

Inotropic Drugs of the Future

Bibliographic reference Pouleur, H. ; Detry, JM. ; Mancia, G.. Inotropic Drugs of the Future. In: European Journal of Clinical Investigation, Vol. 12, no. 6, p. 441-443 (1982)
Permanent URL http://hdl.handle.net/2078.1/57123
  1. Doherty J E, Kane J J, Clinical Pharmacology of Digitalis Glycosides, 10.1146/annurev.me.26.020175.001111
  2. Guz A., Developments in cardiovascular medicine, 255 (1978)
  3. Goldberg Leon I., Use of sympathomimetic amines in heart failure, 10.1016/0002-9149(68)90223-3
  4. Alousi A. A., Farah A. E., Lesher G. Y., Opalka C. J., Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine- 6(1H)-one], 10.1161/01.res.45.5.666
  5. Diederen W, Drug Res, 31, 146 (1981)
  6. 6. EJ. Ariens, Molecular pharmacology. The mode of action of biologically active compounds . New York: Academic Press, 1964 :146 -70 .
  7. Benotti J. R., Grossman W., Braunwald E., Carabello B. A., Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease, 10.1161/01.cir.62.1.28
  8. Jennings K, Eur J Clin Invest, 12, 48 (1982)
  9. Col J, Eur J Clin Invest, 12, 47 (1982)
  10. Hagemeijer F, Eur J Clin Invest, 12, 48 (1982)
  11. Goenen M, Eur J Clin Invest, 12, 48 (1982)
  12. Hansteen V, Br Med J, 284, 155 (1982)
  13. Moss A. J., Davis H. T., Conard D. L., DeCamilla J. J., Odoroff C. L., Digitalis-associated cardiac mortality after myocardial infarction, 10.1161/01.cir.64.6.1150
  14. MANCIA GIUSEPPE, Presidential Address, 10.1111/j.1365-2362.1982.tb02232.x
  15. Coster PM, Eur J Clin Invest, 12, 48 (1982)
  16. Hutton I, Eur J Clin Invest, 12, 48 (1982)
  17. Hamm CW, Eur J Clin Invest, 12, 48 (1982)
  18. Pouleur H, Eur Heart J (1982)